Sidera Bio
Last verified 2026-06-17. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $100.4Mattributed |
|---|---|
| Latest round | series-a, $101.2M, 2025-12-01attributed |
| Founded | 2023 |
| Headquarters | Copenhagen, Denmark |
| Industry | bio |
| Stage | series-a |
| Website | siderabio.com |
Biotech company harnessing human genetics to develop transformative medicines for rare and common diseases
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-12-01 | series-a | $101.2M | undisclosed |
Detected tech stack
cloudflare, hsts, http/3, jquery 3.5.1, webflow
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $101.2M | attributed | sifted named as publisher. No document URL on file. |
| Total raised $100.4M | attributed | sifted named as publisher. No document URL on file. |
| Company existence | self-reported | siderabio.com, read 2026-06-17 |
| Description | self-reported | siderabio.com, read 2026-06-17 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.